Skip to content

Xbox Kinect Training in Men With Prostate Cancer

Xbox Kinect Training in Men With Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01762241
Enrollment
46
Registered
2013-01-07
Start date
2015-02-28
Completion date
2018-06-30
Last updated
2019-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate cancer, Androgen deprivation therapy, Exercise, Xbox

Brief summary

The purpose of this study is to investigate the effect of 12 weeks systematically training using the Xbox Kinect system. Outcome measures are made on physical function, quality of life, fatigue and metabolic parameters.

Detailed description

Patients will be recruited from the outpatient clinic at the urological department, Regionshospitalet Holstebro. Patients who have been discharged from the outpatient clinic due to biochemical stabile cancer prostate disease will receive a letter with information about the study. A research assistant will be responsible for randomization and test procedures. A physiotherapist will be responsible for instruction of the participants to the training and the Xbox system. A student will be responsible for installation and collection of the Xbox system in the participants home.

Interventions

BEHAVIORALHome based training using the Xbox Kinect system

Home based training 3 times a week for 12 weeks using the Xbox Kinect system

Sponsors

Hospitalsenheden Vest
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Prostate cancer requiring androgen deprivation therapy * Androgen deprivation therapy for at least 3 month prior to inclusion * Cognitive well-functioning in order to be able to answer questionnaires and train according to instructions * Signed informed consent

Exclusion criteria

* Prostate cancer with metastasis to other regions than bones * Strength- or cardiovascular training 2 times or more per week prior to inclusion * Haemoglobin percentage less than 6,1 mmol/l * Any mental or physical condition that makes the patient unfit for participation * Men in risk of getting an osteoporotic fracture due to long-term treatment with steroids or earlier fractures due to minimal trauma * Participation in other studies

Design outcomes

Primary

MeasureTime frameDescription
The effect of 12 weeks systematically training with the Xbox Kinect system on physical functionChange from baseline to week 126 min walk test

Secondary

MeasureTime frameDescription
The effect of 12 weeks systematically training with the Xbox Kinect system on physical functionChange from baseline to week 12Leg extensor power
The effect of 12 weeks systematically training with the Xbox Kinect system on fatigueChange from baseline to week 12Fatigue measured using the Functional Assessment of Canter Therapy-Fatigue questionnaire
The effect of 12 weeks systematically training with the Xbox Kinect system on quality of lifeChange from baseline to week 12Quality of life measured using the Functional Assessment of Canter Therapy-Prostate questionnaire
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parametersChange from baseline to week 12Waist circumference (cm)
The effect of 12 weeks systematically training with the Xbox Kinect on body compositionChange from baseline to week 12Method: BIoelectrical impedance analysis Bioelectrical impedance
The effect of 12 weeks systematically training with the Xbox Kinect system on insulinChange from baseline to week 12 and week 24Insulin (pmol/L)
The effect of 12 weeks systematically training with the Xbox Kinect system on insulin resistanceChange from baseline to week 12 and week 24Homeostasis model assessment for insulin resistance (HOMA-IR)
The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor-I (IGF-I), bioactive IGF, and IGF-IIChange from baseline to week 12 and week 24IGF-I, bioactive IGF and IGF-II (µg/L)
The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor Binding Protein 1-3 (IGFBP 1-3)Change from baseline to week 12 and week 24IGFBP 1-3 (µg/L)
The effect of 12 weeks systematically training with the Xbox Kinect system on the prevalence of the metabolic syndromeChange from baseline to week 12The five components of the metabolic syndrome: blood glucose, triglyceride, HDL-cholesterol, waist circumference, blood pressure

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026